Ribo Life Science Completes HK$1.83 Billion Hong Kong IPO

Kirkland & Ellis has advised Suzhou Ribo Life Science Co., Ltd. on its global offering and listing. O’Melveny & Myers has represented the joint sponsors CICC…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here